We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Genip Plc | LSE:GNIP | London | Ordinary Share | GB00BLCW2Q02 | ORD GBP0.00425 |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 31.50 | 3,291 | 08:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 30.00 | 33.00 | 31.50 | 31.50 | 31.50 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 16:14:37 | O | 102 | 31.20 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 03/12/2024 | 17:29 | UK RNS | GenIP PLC TR-1: Notification of major holdings |
| 20/11/2024 | 18:16 | ALNC |  GenIP touts largest single order since launch of its GenAI services |
| 20/11/2024 | 07:00 | UK RNS | GenIP PLC Corporate Update |
| 15/11/2024 | 07:00 | UK RNS | GenIP PLC Healthcare Technology Event in Singapore |
| 22/10/2024 | 06:00 | UK RNS | GenIP PLC GenIP to Sponsor Technology Transfer Conference |
| 10/10/2024 | 06:00 | UK RNS | GenIP PLC GenIP recognises Nobel Prize in Physics |
| 08/10/2024 | 06:00 | UK RNS | GenIP PLC Corporate Update |
| 02/10/2024 | 09:10 | ALNC | TOP NEWS: Tekcapital investee GenIP starts trading on AIM |
| 02/10/2024 | 06:00 | UK RNS | GenIP PLC Admission to Trading on AIM-First Day of Dealings |
Genip (GNIP) Share Charts1 Year Genip Chart |
|
1 Month Genip Chart |
Intraday Genip Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 16/12/2024 | 19:08 | GenIP Artificial Intelligence | 93 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 2024-12-20 16:14:37 | 31.20 | 102 | 31.82 | O |
| 2024-12-20 16:02:34 | 31.20 | 49 | 15.29 | O |
| 2024-12-20 15:57:16 | 31.20 | 52 | 16.22 | O |
| 2024-12-20 15:37:47 | 31.20 | 24 | 7.49 | O |
| 2024-12-20 14:32:36 | 30.05 | 80 | 24.04 | O |
| Top Posts |
|---|
Posted at 16/12/2024 18:43 by buywell3 Strange that Tekcapital AIM holding GNIP did not appear on any Top Riser list todayAs it rose 21% and should have been second on the list Even the LSE did not have it on their list FTSE AIM All-Share RisersFallersVolume leaders INX I-NEXUS GLOBAL PLC 2.00 0.75 (60.00%) VELA VELA TECHNOLOGIES PLC 0.01 0.00 (16.67%) QED QUADRISE PLC 4.65 0.61 (15.10%) VEL VELOCITY COMPOSITES PLC 31.00 4.00 (14.81%) QBT QUANTUM BLOCKCHAIN TECHNOLOGIES PLC 0.83 0.10 (13.79%) SEE SEEING MACHINES LIMITED 4.33 0.43 (11.03%) SCE SURFACE TRANSFORMS PLC 0.44 0.04 (10.13%) SOUC SOUTHERN ENERGY CORP. 6.05 0.55 (10.00%) GENIP PLC Share Company pageOur storyWebcastsTrade recapFundamentalsAna EquityWhat's this? Price (GBX) 31.00 21.57% (5.50) GNIPORD GBP0.00425 Track 1 instrument Open / Last close 25.50 / 31.00 High / Low - / - Bid / Offer 30.00 / 32.00 Special Condition: - Trading Status: Normal - Closed As at 16.12.24 18:21:25 GMT - All data delayed at least 15 minutes |
Posted at 16/12/2024 08:57 by kingston78 The share price will recapture its IPO price of 39 p soon. It is motoring ahead. This is one of my shares for 2025. |
Posted at 14/12/2024 12:18 by jaknife kingston78,"Regarding GenIP, the company was floated at 39 p a share. The company is now more advanced than it was then in terms of development and winning more customers. As it gets more traction, most of the new sales will flow to the bottom line, making it a profitable business. The current price is a real bargain." Do you have any numbers to back up this waffle? I estimate that the company is still hopelessly loss-making and that the pittance that it raised at IPO won't keep it going beyond Q1 next year when it will have to raise more funds. GNIP will have until the end of June 2025 to publish their finals for the year ending 31 Dec 2025. My forecasts for H2/the full-year are: 1. Trivial turnover in H2 of c. £250k 2. Costs of sales of £100k 2. Admin expenses of c. £1.3m (the expenses associated with the IPO were £550k alone plus the cost of running an AIM company for six months) 3. H2 losses of £1,150k 4. This will mean full-year losses of £1,250k, since H1 losses were just under £100k 5. Net assets at year-end of c. £250k. Of which cash will be c. £100k. The £100k won't be enough to keep GNIP going and hence they'll need to raise more cash and/or ramp the share price so that some of the warrants can be exercised. There are 17,517,461 shares in issue ( and so, at the current 25.5p, the market cap is £4.5m! 18 times net assets! What a dog! JakNife |
Posted at 09/12/2024 13:49 by kingston78 Sealand Capital has no business yet, just a conditional agreement to invest into another company that is using AI to advance its business. And yet, Sealand has multiplied from 0.13 p to 2.5 p within 3 weeks (almost 20 times, for late comers they would still have made at least double or triple their money).GENIP has a business and in that regard, Genip'S share price should at least double from here. |
Posted at 30/10/2024 07:57 by neilll77 🚀 TELEGRAM RUMOUR AFTER GenIP TWEET 🚀GenIP [GNIP] about to take off.. the share has been 'kept' under the radar!!!! Rumour of massive AI Health Care contract with a company in Singapore This follows from the below Tweet on X, "Building on deep relationships with leading research organisations, GenIP has been chosen as a preferred partner in Singapore. Further confirmation; once dignitaries, partners, clinicians, and key stakeholders in the healthcare ecosystem will conclude soon" SP nearly 50% below IPO but seller now out and that contract news imminent Big buys already landed today and share price is up 10% M/Cap only 3.3m and TEK [parent company] own over 66% of shares...so a very small "free float" When this moves it can do 15% with a few £1000 pound buys Plus really good news from another TEK 'off spin' SALT today will see much more interest around GenIP and TEK too hxxps://ukinvestorma GLA |
Posted at 15/10/2024 18:41 by jaknife WARNING WARNING WARNING WARNING!Several posters are posting unjustifiable positive spin on here trying to drive the share price up. |
Posted at 11/10/2024 20:17 by retirementfund WARNING WARNING WARNING WARNING!Several Posters are posting negative spin on here trying to drive down the share price. In my opinion |
Posted at 10/10/2024 20:22 by retirementfund WARNING WARNING WARNING WARNING WARNING WARNING WARNING!Several Posters are posting negative spin on here trying to drive down the share price. |
Posted at 08/10/2024 12:17 by retirementfund WARNING WARNING WARNING WARNING WARNING WARNING WARNING WARNING WARNING WARNING!Several Posters are posting negative spin on here trying to drive down the share price. Below is what the company have said in their recent announcement:- 8 October 2024 GenIP Plc ("GenIP" or the "Company") Corporate Update GenIP plc, a technology business providing Generative Artificial Intelligence (GenAI) services to help research organisations and corporations commercialise their innovations, is pleased to provide an update on orders for the GenAI enhanced services since their launch on 1 September 2024. Highlights: · Since launching GenAI services, orders worth approximately $121,000 have been secured, representing over 40% of legacy service full-year 2023 revenue · This includes over 80 Invention Evaluator Generative AI analytical assessments · Winning four Vortechs executive search assignments · Leading Fortune 500 technology company client has doubled the pace of orders after GenAI enhancements · Advanced discussions with multiple research organisations over new orders · GenIP has been Invited to attend leading international technology transfer events by long-term partners The volume of initial orders is very encouraging and the Company anticipates the level of new orders from current and new customers to grow. Invention Evaluator Invention Evaluator's Generative AI algorithms are now fully integrated and are generating enhanced analytical commercialisation assessments for our clients at a high efficiency level. Since the beginning of September 2024, new and existing clients have placed over 80 fresh orders for Invention Evaluator Generative AI analytical assessments. Vortechs Vortechs' advanced machine learning and natural language processing executive search services has received several new assignments in the technology transfer sector. GenIP's sales team is engaged in advanced negotiations with multiple research organisations representing a robust Vortechs pipeline of new business. International Technology Transfer Event Participation Building on deep relationships with leading research organisations, GenIP has been invited to attend a significant healthcare event in Singapore, where dignitaries, partners, clinicians, and key stakeholders in the healthcare ecosystem will gather. In addition, GenIP will address delegates at a major technology transfer event in Brazil. This event will bring together over 500 qualified attendees, including representatives from more than 60 Technology Transfer Offices (TTOs) across Brazilian universities and research centres. GenIP looks forward to providing further updates on commercial progress in due course. The Company does not plan to provide monthly updates on sales or orders and will provide updates on material developments. Melissa Cruz, CEO of GenIP, comments: "We are highly encouraged by the strong demand for GenIP's Generative AI analytic services over the past five weeks, with total orders amounting to approximately $121,000. We remain laser-focused on building on this momentum, expanding our client base, and delivering our services to research organisations globally." In my opinion |
Posted at 07/10/2024 12:53 by neilll77 I have sent this email to investor relations and will post their reply, if I receive 1.Good afternoon, I think we need an via update of trading and the plans for the immediate future, as the share price is crashing. Also you may want to question LSE why the share price drops on £250 sells , but buys upto and over £6000 are not moving the share price At 25.30p it is now over 40% down from IPO price!! As an investor in GenIP, I'm very frustrated and disappointed Regards and I'd really appreciate a reply |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
